mark,

ICAN recently sent an urgent letter to FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) before its last meeting, documenting alarming safety and efficacy failures with Moderna’s new mRNA flu vaccine, mFlusiva.

Shockingly, the committee voted unanimously to recommend mFlusiva anyway. It now goes to FDA Acting Commissioner Kyle Diamantas for official approval.

ICAN raised several concerns with mFlusiva, including…

The most infuriating part of the VRBPAC meeting was that the members actually acknowledged and discussed some of these concerns, but instead of postponing its recommendation, the committee simply recommended that further studies be done after mFlusiva’s approval. Meaning, America’s most vulnerable seniors will once again be used as guinea pigs while the FDA takes years to figure out if the vaccine is actually harming people.

Obviously, you know by now that ICAN will not back down. ICAN’s Legal Team is laser-focused on this issue. That’s why ICAN has earned the title “America’s Public Health Watchdog” by filing roughly 146 federal lawsuits, forcing the government to release over 8 million pages of data, and taking 23 federal agencies to court. We know how to fight—and we know how to win.

To that end, ICAN will continue to raise concerns about mFlusiva and, if it is approved, we will be filing FOIA requests to obtain the full clinical trial data the FDA doesn’t want you to see.

Yet, our legal work and investigative work all rely 100% upon you!

Funding legal challenges and amplifying these revelations depend on resources. The corporate media blacked out the biggest health scandal of all time. We must pay for our own media and continue to produce our weekly news show, The HighWire, where we conduct our own investigations.

If you like what we’re doing and you want to see more of it, stand with us today.

Your gift of $50, $100, or whatever you can afford will be put to immediate use.

And I’d be remiss if I didn’t tell you that nearly 93% of every dollar raised is poured back into our critical mission’s work.

Very few nonprofits are able to say that, and it’s because of your support today, tomorrow, and the next day that we can!

Be Brave!